A randomized cross-over study with objective quantification of the performance of an asymmetric triacetate and a polysulfone dialysis membrane using different anticoagulation strategies.
anticoagulation
clotting
haemodialysis
micro-CT scan
polymers
Journal
Clinical kidney journal
ISSN: 2048-8505
Titre abrégé: Clin Kidney J
Pays: England
ID NLM: 101579321
Informations de publication
Date de publication:
Jan 2021
Jan 2021
Historique:
received:
19
07
2019
accepted:
02
10
2019
entrez:
10
2
2021
pubmed:
22
12
2019
medline:
22
12
2019
Statut:
epublish
Résumé
Different strategies can be used to counteract coagulation of extracorporeal systems. Systemic anticoagulation is most widely used in routine clinical practice, but can be contraindicated in specific settings. The Solacea This cross-over study with four arms randomized consecutively 10 maintenance haemodialysis patients to a 4-h post-dilution haemodiafiltration session at midweek, using either Solacea The relative number of open fibres post-dialysis was lower in FX800CORDIAX versus Solacea The Solacea
Sections du résumé
BACKGROUND
BACKGROUND
Different strategies can be used to counteract coagulation of extracorporeal systems. Systemic anticoagulation is most widely used in routine clinical practice, but can be contraindicated in specific settings. The Solacea
METHODS
METHODS
This cross-over study with four arms randomized consecutively 10 maintenance haemodialysis patients to a 4-h post-dilution haemodiafiltration session at midweek, using either Solacea
RESULTS
RESULTS
The relative number of open fibres post-dialysis was lower in FX800CORDIAX versus Solacea
CONCLUSIONS
CONCLUSIONS
The Solacea
Identifiants
pubmed: 33564444
doi: 10.1093/ckj/sfz163
pii: sfz163
pmc: PMC7857793
doi:
Types de publication
Journal Article
Langues
eng
Pagination
398-407Commentaires et corrections
Type : ErratumIn
Informations de copyright
© The Author(s) 2019. Published by Oxford University Press on behalf of ERA-EDTA.
Références
Nefrologia. 2018 Mar - Apr;38(2):161-168
pubmed: 29198593
Nephrol Dial Transplant. 2006 Aug;21(8):2191-201
pubmed: 16567341
Int J Artif Organs. 1996 Jul;19(7):404-10
pubmed: 8841854
Contrib Nephrol. 2017;189:215-221
pubmed: 27951571
Semin Nephrol. 1994 May;14(3):205-18
pubmed: 8036355
Artif Organs. 2019 Aug;43(8):756-763
pubmed: 30820962
Contrib Nephrol. 2017;191:168-177
pubmed: 28910800
Clin Nephrol. 2007 Nov;68(5):302-7
pubmed: 18044262
Ther Apher Dial. 2011 Jun;15(3):278-82
pubmed: 21624076
Nephrol Dial Transplant. 2010 Oct;25(10):3337-42
pubmed: 20466660
Blood Purif. 2019;48(2):167-174
pubmed: 30943486
Am J Kidney Dis. 2005 Mar;45(3):557-64
pubmed: 15754278
Kidney Int. 2014 Dec;86(6):1260-7
pubmed: 25007166
Am J Kidney Dis. 2016 Nov;68(5):752-762
pubmed: 27344212
Nephrol Dial Transplant. 1998 Jul;13(7):1752-8
pubmed: 9681723
Int J Artif Organs. 1989 Jun;12(6):356-65
pubmed: 2674019
BMC Nephrol. 2014 Jul 03;15:104
pubmed: 24993584
Toxins (Basel). 2018 Jan 08;10(1):
pubmed: 29316724
Kidney Int. 1986 Sep;30(3):429-32
pubmed: 3784285
J Nephrol. 2008 Mar-Apr;21(2):146-60
pubmed: 18446708
Nephrol Dial Transplant. 2017 Jan 1;32(1):165-172
pubmed: 27587605
Nephrol Dial Transplant. 2011 Aug;26(8):2624-30
pubmed: 21310741
J Am Soc Nephrol. 2013 Dec;24(12):1981-94
pubmed: 24009240
Clin Kidney J. 2018 Oct;11(5):742-746
pubmed: 30288272
Contrib Nephrol. 1985;46:14-22
pubmed: 4006473
Nephron. 2000 Aug;85(4):334-42
pubmed: 10940744
Sci Rep. 2018 Feb 8;8(1):2677
pubmed: 29422614
Nephrol Dial Transplant. 2002;17 Suppl 7:63-71
pubmed: 12386229
Am J Kidney Dis. 2007 May;49(5):642-9
pubmed: 17472846
Clin Kidney J. 2018 Dec 15;12(3):447-455
pubmed: 31198548